Loading stock data…
GOCO
$1.11-0.02 (-1.77%)
Market ClosedLast close May 1
GoHealth, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
GoHealth, Inc. in the Financial Services sector is trading at $1.11. The stock is currently near its 52-week low of $1.00, remaining 65.5% below its 200-day moving average. Technical signals show neutral RSI of 52 and bullish MACD crossover, explaining why GOCO maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.11
Potential Upside
5%
Whystock Fair Value$1.17
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Buy
Mean target$4.70+323.4%
Range$1.50 – $10.00
Fundamentals
GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company offers Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special nee...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$36.06M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.60
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-255.74%
Volume
Today's trading volume
66,813
Recent News
How The GoHealth (GOCO) Narrative Is Shifting After Target Reset And Nasdaq Compliance Risks
GoHealth’s analyst fair value estimate has shifted from US$7.70 to US$4.70, bringing the price target closer to the recent reset discussed earlier. Some analysts with a more optimistic view see this new level as a cleaner entry point and a better reflection of execution risk. In contrast, more cautious analysts view the cut as a reminder that earlier forecasts may have been too optimistic. As you read on, you will see how to track this evolving narrative and what to watch for in the next...
GoHealth (GOCO) Reports Q4 Loss, Misses Revenue Estimates
GoHealth (GOCO) delivered earnings and revenue surprises of +61.71% and -84.70%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Looking At The Narrative For GoHealth (GOCO) After Q3 Reset And Carrier Shakeup
The latest update on GoHealth keeps the fair value target steady at 7.7 with the discount rate unchanged at 12.5%, so the core valuation framework remains intact even as expectations around the business are recalibrated. Revenue growth assumptions now reflect roughly a 10.75% decline, which ties back to weaker Q3 trends and the impact of a suspended carrier relationship, while still acknowledging bullish views that tighter cash burn and more disciplined enrollment could create a cleaner base...
How The GoHealth (GOCO) Story Is Changing As Analysts Reset Expectations
Recent updates to GoHealth’s price target are less about a change in the headline fair value, which stays at 7.7, and more about how analysts are thinking about the path the company might take to get there. With the discount rate still at 12.5% and revenue expectations pointing to a slightly smaller 10.75% decline, the latest narrative reflects both the weaker Q3 showing and management’s focus on cash discipline and tighter growth ambitions. As these inputs are refreshed to match new carrier...
How Recent Earnings Are Shaping the GoHealth Story and Its Investment Outlook
GoHealth’s fair value estimate has been sharply lowered from $14 to $7.70 per share following the company’s latest earnings and operational performance updates. Analysts cite weaker revenue forecasts as the reason for the adjustment, reflecting both recent challenges and cautious optimism around management’s focus on stability. Stay tuned to discover how developments like these can help you track important shifts in the stock’s outlook going forward. Stay updated as the Fair Value for...